logo
Select company
Select metric
$ 13.37KCapital Expenditure
VS
Market
84
Sector
73
Industry
74
History
-
$ 1.82Close
$ 1.53 - $ 2.27 52-Week Range
Ticker Information

Ticker

APUS

Company Name

APIMEDS PHARMACEUTICALS US INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSEMKT

APIMEDS PHARMACEUTICALS US INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

APUS - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 13.37K
12/31/2024$ 0
12/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • APIMEDS PHARMACEUTICALS US INC's latest trailing twelve months (TTM) CapEx stands at $ 0.
  • Over the past 5 years, APIMEDS PHARMACEUTICALS US INC's average CapEx has been $ 4.46K.
  • The median CapEx for APIMEDS PHARMACEUTICALS US INC during this period was $ 0
  • APIMEDS PHARMACEUTICALS US INC reached its highest CapEx over the past 5 years at $ 13.37K.
  • The lowest CapEx recorded by APIMEDS PHARMACEUTICALS US INC in the same timeframe $ 0

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

APUS - Capital Expenditure, Last 5 years

$ 0

Minimum

Dec 31, 2023

$ 13.37K

Maximum

Jun 30, 2025

$ 4.46K

Average

$ 0

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.65M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.65M
median$ 1.92M
std$ 15.86M